Donor information based prediction of early allograft dysfunction and outcome in liver transplantation

Liver International

Volumn 35, Issue 1, 2015, Pages 156-163

  Hoyer, Dieter P ^a   Paul, Andreas ^a   Gallinat, Anja ^a   Molmenti, Ernesto P ^b   Reinhardt, Renate ^a   Minor, Thomas ^c   Saner, Fuat H ^a   Canbay, Ali ^a   Treckmann, Jürgen W ^a   Sotiropoulos, Georgios C ^a   Mathé, Zoltan ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^c UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Donor risk factors; Early allograft dysfunction; Liver transplantation; Multivariable analysis; Scoring system

Indexed keywords

BILIRUBIN; CALCINEURIN INHIBITOR; CREATININE; HYPERTENSIVE FACTOR; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; SODIUM;

ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; BODY MASS; BODY WEIGHT; CAUSE OF DEATH; COLD ISCHEMIA; CREATININE BLOOD LEVEL; DRUG MEGADOSE; EARLY ALLOGRAFT DYSFUNCTION; FATTY LIVER; FEMALE; GRAFT DYSFUNCTION; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; HYPERTRANSAMINASEMIA; IMMUNOSUPPRESSIVE TREATMENT; INTRAOPERATIVE PERIOD; LENGTH OF STAY; LIVER BIOPSY; LIVER GRAFT; LIVER TRANSPLANTATION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; ORGAN DONOR; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PREDICTION; PREDICTIVE VALUE; PREDICTOR VARIABLE; PROGNOSIS; RISK FACTOR; SEX DIFFERENCE; SODIUM BLOOD LEVEL; SURVIVAL; TREATMENT OUTCOME; ADVERSE EFFECTS; AGE; ALLOGRAFT; BLOOD; DONOR; KAPLAN MEIER METHOD; ORGAN DYSFUNCTION SCORE; PATHOPHYSIOLOGY; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; VALIDATION STUDY;

ADULT; AGE FACTORS; ALLOGRAFTS; BILIRUBIN; BODY MASS INDEX; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER TRANSPLANTATION; LOGISTIC MODELS; MALE; MIDDLE AGED; ORGAN DYSFUNCTION SCORES; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SEX FACTORS; TISSUE DONORS;

EID: 84921025356     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12443     Document Type: Article

References (31)

1. Radunz S, Paul A, Nowak K, et al. Liver transplantation using donor organs with markedly elevated liver enzymes: how far can we go? Liver Int 2011; 31: 1021.
2. Olthoff KM, Kulik L, Samstein B, et al. Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors. Liver Transpl 2010; 16: 943.
3. Wong C, Lee W, Jenq C, et al. Scoring short-term mortality after liver transplantation. Liver Transpl 2010; 16: 138.
4. Hong JC, Kaldas FM, Kositamongkol P, et al. Predictive index for long-term survival after retransplantation of the liver in adult recipients: analysis of a 26-year experience in a single center. Ann Surg 2011; 254: 444.
5. Ghobrial RM, Gornbein J, Steadman R, et al. Pretransplant model to predict posttransplant survival in liver transplant patients. Ann Surg 2002; 236: 315.
6. Deschênes M, Belle SH, Krom RA, Zetterman RK, Lake JR. Early allograft dysfunction after liver transplantation: a definition and predictors of outcome. Transplantation 1998; 66: 302.
7. González FX, Rimola A, Grande L, et al. Predictive factors of early postoperative graft function in human liver transplantation. Hepatology 1994; 20: 565.
8. Nanashima A, Pillay P, Verran DJ, et al. Analysis of initial poor graft function after orthotopic liver transplantation: experience of an australian single liver transplantation center. Transpl Proc 2002; 34: 1231.
9. Ploeg RJ, D'Alessandro AM, Knechtle SJ, et al. Risk factors for primary dysfunction after liver transplantation - a multivariate analysis. Transplantation 1993; 55: 807.
10. Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006; 6: 783.
11. Blok JJ, Braat AE, Adam R, et al. Validation of the donor risk index (DRI) in orthotopic liver transplantation within the eurotransplant region. Liver Transpl 2012; 18: 112.
12. Donders ART, van der Heijden GJMG, Stijnen T, Moons KGM. Review: a gentle introduction to imputation of missing values. J Clin Epidemiol 2006; 59: 1087.
13. Segev DL, Kucirka LM, Nguyen GC, et al. Effect modification in liver allografts with prolonged cold ischemic time. Am J Transplant 2008; 8: 658.
14. Foley DP, Fernandez LA, Leverson G, et al. Biliary complications after liver transplantation from donation after cardiac death donors: an analysis of risk factors and long term outcomes from a single center. Ann Surg 2011; 253: 817.
15. Park JB, Kwon CHD, Choi G-S, et al. Prolonged cold ischemic time is a risk factor for biliary strictures in duct-to-duct biliary reconstruction in living donor liver transplantation. Transplantation 2008; 86: 1536.
16. Agopian VG, Kaldas FM, Hong JC, et al. Liver transplantation for nonalcoholic steatohepatitis: the new epidemic. Ann Surg 2012; 256: 624.
17. Perez-Daga JA, Santoyo J, Suárez MA, et al. Influence of degree of hepatic steatosis on graft function and postoperative complications of liver transplantation. Transpl Proc 2006; 38: 2468.
18. Zamboni F, Franchello A, David E, et al. Effect of macrovescicular steatosis and other donor and recipient characteristics on the outcome of liver transplantation. Clin Transpl 2001; 15: 53.
19. Angelico M. Donor liver steatosis and graft selection for liver transplantation: a short review. Eur Rev Med Pharmacol Sci 2005; 9: 295.
20. McCormack L, Petrowsky H, Jochum W, et al. Use of severely steatotic grafts in liver transplantation: a matched case-control study. Ann Surg 2007; 246: 940.
21. Spitzer AL, Lao OB, Dick AAS, et al. The biopsied donor liver: incorporating macrosteatosis into high-risk donor assessment. Liver Transpl 2010; 16: 874.
22. Braat AE, Blok JJ, Putter H, et al. The Eurotransplant Donor Risk Index in liver transplantation: ET-DRI. Am J Transplant 2012; 12: 2789.
23. Arnlöv J, Ingelsson E, Sundström J, Lind L. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation 2010; 121: 230.
24. Lteif AA, Han K, Mather KJ. Obesity, insulin resistance, and the metabolic syndrome: determinants of endothelial dysfunction in whites and blacks. Circulation 2005; 112: 32.
25. Schlitt HJ, Loss M, Scherer MN, et al. Current developments in liver transplantation in Germany: MELD-based organ allocation and incentives for transplant centres. Z Gastroenterol 2011; 49: 30.
26. Rana A, Hardy MA, Halazun KJ, et al. Survival outcomes following liver transplantation (SOFT) score: a novel method to predict patient survival following liver transplantation. Am J Transplant 2008; 8: 2537.
27. Weismüller TJ, Prokein J, Becker T, et al. Prediction of survival after liver transplantation by pre-transplant parameters. Scand J Gastroenterol 2008; 43: 736.
28. Feng S. The dilemma of high-risk deceased donor livers: who should get them? Liver Transpl 2010; 16: S60.
29. Schemmer P, Nickkholgh A, Gerling T, et al. Rescue allocation for liver transplantation within Eurotransplant: the Heidelberg experience. Clin Transpl 2009; 23(Suppl 2): 42.
30. Sotiropoulos GC, Paul A, Gerling T, et al. Liver transplantation with "rescue organ offers" within the eurotransplant area: a 2-year report from the University Hospital Essen. Transplantation 2006; 82: 304.
31. Sotiropoulos GC, Lang H, Saner FH, et al. Long-term results after liver transplantation with "livers that nobody wants" within Eurotransplant: a center's experience. Transplant Proc 2008; 40: 3196.